Register to receive a free U.S. Market Report Suite for Infusion Therapy Device –MedSuite report synopsis and brochure InfuSystem Holdings, a leading national provider of infusion pumps and related services for the healthcare industry in the United States and Canada, announced the launch of InfuSystem Mobile, its innovative infusion patient safety app for smartphones and tablets. InfuSystem
Register to receive a free U.S. Market Report Suite for Infusion Therapy Device –MedSuite report synopsis and brochure With a long history of supporting the home infusion market, B. Braun Medical Inc. will showcase its extensive portfolio of products, services, and technology at this year’s National Home Infusion Association (NHIA) Conference & Exposition at the Phoenix Convention
Register to receive a free U.S. Market Report Suite for Infusion Therapy Device – MedSuite report synopsis and brochure South Texas Blood & Tissue Center, a subsidiary of BioBridge Global, today launched a program to aid accident and trauma patients served by area air medical services and hospital helicopters. The program, “Brothers in Arms,” will enable air
As part of its participation with government agencies, BD is participating in the National Institute of Standards and Technology (NIST) Secure Wireless Infusion Pump Program and created a white paper for secure design and architecture.
The overall U.S. infusion therapy device market is expected to increase and exceed an estimated $2.7 billion by 2024.
The main challenge facing health care providers and device manufacturers is how to make this therapy safer but also more accessible. The industry addresses this challenge in two ways. On the one hand, recent market consolidation, conducted primarily though mergers and acquisitions has provided resources for additional R&D activities.
This trend will be solely driven by continued growth in unit sales as the average selling price (ASP) of all device types has been decreasing due to fierce competition and sluggish economic conditions.
Overall, the Europe infusion therapy devices market value is expected to increase to exceed €1 billion by 2023.
